Cindy Eckert first learned about hypoactive sexual desire disorder (HSDD)—the most common type of sexual dysfunction in women—while attending a conference as a cofounder of Slate Pharmaceuticals, a male-hormone company. (At the time, Slate’s main drug was a testosterone treatment.) During a presentation, scientists showed brain scan images comparing how women with normal desire and women with HSDD reacted to …
Read More »How Cindy Eckert Fought For Women’s Desire—And Continues To Win
